scholarly journals Non-Alcoholic Fatty Liver Disease (NAFLD) in Children and Adolescents taking Atypical Antipsychotic Medications: A Protocol for Systematic Review and Meta-Analysis (Preprint)

10.2196/20168 ◽  
2021 ◽  
Author(s):  
Reem Hatem ◽  
Faisal A. Nawaz ◽  
Ghadah A. Al-Sharif ◽  
Mohammad Almoosa ◽  
Wid Kattan ◽  
...  
2021 ◽  
Author(s):  
Reem Hatem ◽  
Faisal A. Nawaz ◽  
Ghadah Al-Sharif ◽  
Mohammad Iyad Almoosa ◽  
Wid Kattan ◽  
...  

Atypical Antipsychotic medications are commonly prescribed to children and adolescents and are associated with important adverse effects including weight gain and metabolic syndrome. Non-Alcoholic Fatty Liver Disease (NAFLD) is not only the most common pediatric liver disease, but can also be associated with serious complications including liver cirrhosis. Given that both NAFLD and Atypical Antipsychotics (AAP) are associated with metabolic syndrome, we aimed to comprehensively examine the association between AAP and NAFLD in children and adolescents. We will conduct a systematic review following the PRISMA guidelines, of English-language literature published between 1950 and 2019, exploring NAFLD in subjects younger than 18 years on AAP.


PLoS ONE ◽  
2015 ◽  
Vol 10 (10) ◽  
pp. e0140908 ◽  
Author(s):  
Emma L. Anderson ◽  
Laura D. Howe ◽  
Hayley E. Jones ◽  
Julian P. T. Higgins ◽  
Debbie A. Lawlor ◽  
...  

2018 ◽  
Vol 17 (3) ◽  
pp. 345-354 ◽  
Author(s):  
Melina Utz-Melere ◽  
Cristina Targa-Ferreira ◽  
Bernardo Lessa-Horta ◽  
Matias Epifanio ◽  
Marialena Mouzaki ◽  
...  

2018 ◽  
Vol 6 ◽  
pp. 205031211774522 ◽  
Author(s):  
Arash Akhavan Rezayat ◽  
Malihe Dadgar Moghadam ◽  
Mohammad Ghasemi Nour ◽  
Matin Shirazinia ◽  
Hamidreza Ghodsi ◽  
...  

Background/aims: Non-alcoholic fatty liver disease is one of the most common chronic liver diseases. Some risk factors are known to influence the development of non-alcoholic fatty liver disease, but the effect of tobacco smoking on the progression of non-alcoholic fatty liver disease is controversial. The main goal of this systematic review and meta-analysis is to investigate the association between smoking and non-alcoholic fatty liver disease. Method: Electronic databases (PubMed, Scopus, and ISI Web of Science) were searched to find published articles on non-alcoholic fatty liver disease and smoking until December 2016. All relevant studies were screened by inclusion and exclusion criteria and compatible studies were chosen. The Newcastle–Ottawa Scale was used to assess the methodological quality of eligible articles. Subsequently, information was gathered based on the following: author, publication year, keywords, country, inclusion and exclusion criteria, main results, study design, conclusion, and confounder variables (age, body mass index, gender, ethnicity, and diabetes). Finally, analyses were performed using Comprehensive Meta-Analysis Software. Results: Data were extracted from 20 observational studies (9 cross-sectional, 6 case-control, 4 cohort studies, and 1 retrospective cohort study). A significant association was observed between smoking and non-alcoholic fatty liver disease with a pooled odds ratio of 1.110 (95% confidence interval, 1.028–1.199), p-value = 0.008. The statistical heterogeneity was medium with an I2 of 40.012%, p-heterogeneity = 0.074. Also there was a significant relation between non-alcoholic fatty liver disease and passive smoking with a pooled odds ratio of 1.380 (95% confidence interval, 1.199–1.588; p-value = 0.001; I2 = 59.41; p-heterogeneity = 0.117). Conclusion: Our meta-analysis demonstrated that smoking is significantly associated with non-alcoholic fatty liver disease. Further prospective studies exploring the underlying mechanisms of this association should be pursued. Also passive smoking increases the risk of non-alcoholic fatty liver disease about 1.38-fold. The effects of smoking cigarettes on active smokers (current smoker, former smoker, and total smoker) are less than passive smokers. Further studies are needed to compare the of effects of passive and active smoking on non-alcoholic fatty liver disease.


Sign in / Sign up

Export Citation Format

Share Document